NICE publishes new rapid guideline on COVID-19 and radiotherapy March 2020 NICE has published the next in its series of rapid guidelines on coronavirus (COVID-19), COVID-19 rapid guideline: delivery of radiotherapy. The guideline was produced to maximise […]
NICE calls for further data collection to support the development of histology-independent cancer treatments March 2020 As a member of the NHS Accelerated Access Collaborative (AAC)—a cross-sector partnership aimed at accelerating access to transformative health technologies—NICE has called for further data […]
NICE approval of innovative drugs slows down March 2020 A report by the Institute of Cancer Research (ICR) suggests that the pace at which NICE is approving innovative drugs for use in the NHS […]
Update on review of children’s cancer services March 2020 NHS England and Improvement have issued an update on their review of children’s cancer services. This follows a series of consultations on proposed changes to […]
Implementing the latest NICE lung cancer guidance February 2020 | By Mick Peake Lung cancer remains the UK’s biggest cancer killer: in the UK, the condition was responsible for over 35,000 deaths between 2015 and 2017.1 The disease […]
Implementing the NHS Cancer Plan: challenges and opportunities February 2020 | By Alastair Whitington The Commissioning Chemotherapy Services Conference 2019 was held on 26 November 2019 at the Pullman London St Pancras Hotel, London. Professor Peter Johnson, National Clinical […]
